Dr. Zimri is the VP of R&D at NeuroSense Therapeutics, leading the research and development programs for ALS, Parkinson’s disease, and Alzheimer’s disease.
Shiran is a pre-clinical drug development expert, with over 12 years of experience studying neurodegenerative diseases utilizing multidisciplinary methods.
She has been published in leading journals and has presented at scientific conferences worldwide.
Dr. Zimri is a member of the BIO committee, a member of “Bashaar,” an academic community for society in Israel, and a member of “Midaat,” a non-profit organization promoting public health.
Shiran holds a Ph.D. in Neurobiology from Tel Aviv University.